A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced and Selected Solid Tumors
Interventions: DRUG: BKM120|DRUG: GSK1120212
Sponsor: Novartis Pharmaceuticals